CME Group Inc. (CME) Stock Analysis
Financial Services · Financial Data & Stock Exchanges · NasdaqGS
CME Group Inc. (CME) posted $6.52B in revenue for fiscal 2025 (up 6.4% year over year), at a 61.7% net margin, and has compounded revenue about 6.0%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on CME Group Inc.
CME Group Inc. has grown revenue from $3.60B to $6.52B over the last 10 fiscal years, compounding about 6% a year. The most recent year was up 6.4%, roughly in line with its longer-run pace.
Net margin sits at 61.7%, up 4.9 points year over year.
At today's valuation the market is pricing in roughly 9.6% annual free-cash-flow growth — versus the 10.7% it actually delivered over the last five years, broadly in line with what it has delivered.
Synthesised from CME Group Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
CME Group Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.60B | $3.64B | $4.31B | $4.87B | $4.88B | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Net income | $1.53B | $4.06B | $1.96B | $2.12B | $2.11B | $2.64B | $2.66B | $3.19B | $3.48B | $4.02B |
| Net margin | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 52.9% | 57.1% | 56.8% | 61.7% |
Source: CME Group Inc. SEC filings (10-K). 19 years of history available in the interactive view.
CME Group Inc.: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
What growth is priced into CME stock?
At today's market cap of $96.29B, CME Group Inc. is priced for free-cash-flow growth of about 9.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $4.19B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 10.7%/yr over the last five fiscal years and revenue 6%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 19 years of CME Group Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CME in your portfolio →
CME Group Inc. financial history by metric
Compare CME Group Inc. with peers
About CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. CME Group Inc. partners with FutureSports to futures on sports indexes. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
CME Group Inc. — frequently asked questions
What is CME Group Inc.'s revenue?
CME Group Inc. (CME) reported revenue of $6.52B for fiscal year 2025, up 6.4% from the prior year, according to its SEC filings.
Is CME Group Inc. profitable?
Yes. CME earned net income of $4.02B in fiscal 2025, a net margin of 61.7%.
What is CME's P/E ratio?
CME Group Inc. trades at a price-to-earnings ratio of about 22.7 based on the latest data in our nightly-refreshed cache.
How fast is CME Group Inc. growing?
CME's revenue grew at roughly 6.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does CME Group Inc. have?
As of fiscal year 2025, CME carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is CME Group Inc.'s market cap?
CME Group Inc. (CME) has a market capitalization of about $96.29B, based on the latest data in our nightly-refreshed cache.
When does CME Group Inc.'s fiscal year end?
CME's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CME stock?
At today's market cap of $96.29B, CME Group Inc. is priced for free-cash-flow growth of about 9.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $4.19B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 10.7%/yr over the last five fiscal years and revenue 6%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from CME Group Inc.'s official SEC filings (10-K and 10-Q), covering 19 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.